Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Merit Medical Systems ( (MMSI) ) has shared an update.
On April 30, 2026, Merit Medical reported first-quarter 2026 results that beat its own expectations, with revenue rising 7% year over year to $381.9 million, GAAP EPS climbing 39% to $0.68, and non-GAAP EPS up 9% to $0.94, supported by improved operating margins and a 26% increase in free cash flow. During the quarter and shortly after, the company sold its non-core DualCap product line for $28 million, completed the $140 million acquisition of View Point Medical’s OneMark oncology system, reorganized reporting into Foundational and Therapeutic categories, and slightly raised its 2026 revenue outlook to $1.612–$1.634 billion, underscoring its push toward higher-margin growth in a large and expanding oncology market while maintaining solid liquidity and borrowing capacity.
The most recent analyst rating on (MMSI) stock is a Buy with a $107.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Neutral.
Score is driven primarily by strong financial performance (profitability improvement and robust cash generation) and a constructive earnings outlook despite identified headwinds. Offsetting these strengths are weak technical momentum (below key moving averages with negative MACD) and a relatively expensive valuation (P/E ~40.6) with no dividend yield provided.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Merit Medical Systems, Inc., based in South Jordan, Utah, is a leading global manufacturer and marketer of healthcare technology. The company offers a diverse portfolio of foundational and therapeutic medical products, with a growing focus on therapeutic oncology, and serves hospitals and clinicians worldwide across a range of interventional and surgical specialties.
Average Trading Volume: 728,033
Technical Sentiment Signal: Sell
Current Market Cap: $3.87B
For detailed information about MMSI stock, go to TipRanks’ Stock Analysis page.